EORTC protocol 55857

Phase II trial of 5-aza-2'-deoxycytidine in patients with advanced or recurrent squamous cell carcinoma of the uterine cervix
Trial StatusAll trial activities ended
DatesDate of activation: 15-Jan-86
Closed on : 15-Apr-89
Data management at EORTCFull
Phase2
Randomized trialNo
TypeAdvanced
Targeted Sample size14
Number of steps1
Drug
Study StaffJan Baptist Vermorken (Study Coordinator) - Universitair Ziekenhuis Antwerpen, Edegem
Type of cancerCervical
Participating GroupsEORTC Gynecological Cancer Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT
Back to Protocol section